Question 1

What is the catalog number for Mouse Monoclonal P2X1/P2RX1 Antibody (551820) [DyLight 594]?

Accepted Answer

The catalog number for Mouse Monoclonal P2X1/P2RX1 Antibody (551820) [DyLight 594] is FAB10533M.

Question 2

What sizes are available for Mouse Monoclonal P2X1/P2RX1 Antibody (551820) [DyLight 594]?

Accepted Answer

Mouse Monoclonal P2X1/P2RX1 Antibody (551820) [DyLight 594] is available in the following size(s): 0.1 mL.

Question 3

Is Mouse Monoclonal P2X1/P2RX1 Antibody (551820) [DyLight 594] in stock?

Accepted Answer

Mouse Monoclonal P2X1/P2RX1 Antibody (551820) [DyLight 594] is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 5

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 6

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Mouse Monoclonal P2X1/P2RX1 Antibody (551820) [DyLight 594]

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

Anti-NUDCD1 Antibody Picoband®, Cy3 Conjugate

CD31 / PECAM-1 (Endothelial Cell Marker), CF740 conjugate, 0.1mg/mL

CD45RA (PTPRC/1148), CF594 conjugate, 0.1mg/mL

CD45RB (PTPRC/1147), Biotin conjugate, 0.1mg/mL

Human recombinant IL-33 (Interleukin-33) protein, AF

COX2 Mouse Monoclonal Antibody [A3F8]